Givaudan (GVDNY)
(Delayed Data from OTC)
$88.33 USD
-0.13 (-0.15%)
Updated May 6, 2024 03:59 PM ET
3-Hold of 5 3
F Value A Growth C Momentum C VGM
Income Statements
Fiscal Year end for Givaudan SA falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 7,703 | 7,458 | 7,313 | 6,743 | 6,244 |
Cost Of Goods | 4,532 | 4,564 | 4,189 | 3,907 | NA |
Gross Profit | 3,170 | 2,894 | 3,124 | 2,836 | NA |
Selling & Adminstrative & Depr. & Amort Expenses | 1,927 | 1,729 | 1,932 | 1,774 | 0 |
Income After Depreciation & Amortization | 1,243 | 1,165 | 1,191 | 1,062 | 0 |
Non-Operating Income | -8 | -88 | -33 | -36 | NA |
Interest Expense | 134 | 105 | 103 | 92 | NA |
Pretax Income | 1,102 | 972 | 1,056 | 934 | NA |
Income Taxes | 107 | 75 | 158 | 142 | NA |
Minority Interest | 0 | 0 | 0 | 0 | NA |
Investment Gains/Losses | 0 | 0 | 0 | 0 | NA |
Other Income/Charges | 0 | 0 | 0 | 0 | NA |
Income From Cont. Operations | 995 | 897 | 898 | 792 | 707 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | 995 | 897 | 898 | 792 | 707 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 1,640 | 1,547 | 1,618 | 1,476 | 0 |
Depreciation & Amortization (Cash Flow) | 397 | 381 | 427 | 414 | NA |
Income After Depreciation & Amortization | 1,243 | 1,165 | 1,191 | 1,062 | 0 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 461.21 | 461.06 | 464.52 | 460.98 | 464.35 |
Diluted EPS Before Non-Recurring Items | 2.16 | 1.93 | 1.93 | 1.80 | 1.52 |
Diluted Net EPS (GAAP) | 2.15 | 1.94 | 1.93 | 1.71 | 1.52 |
Fiscal Year end for Givaudan SA falls in the month of December .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | NA | NA | NA | NA | NA |
Cost Of Goods | NA | NA | NA | NA | NA |
Gross Profit | NA | NA | NA | NA | NA |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Non-Operating Income | NA | NA | NA | NA | NA |
Interest Expense | NA | NA | NA | NA | NA |
Pretax Income | NA | NA | NA | NA | NA |
Income Taxes | NA | NA | NA | NA | NA |
Minority Interest | NA | NA | NA | NA | NA |
Investment Gains/Losses | NA | NA | NA | NA | NA |
Other Income/Charges | NA | NA | NA | NA | NA |
Income From Cont. Operations | NA | NA | NA | NA | NA |
Extras & Discontinued Operations | NA | NA | NA | NA | NA |
Net Income (GAAP) | NA | NA | NA | NA | NA |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | NA | NA | NA | NA | NA |
Diluted EPS Before Non-Recurring Items | NA | NA | NA | NA | NA |
Diluted Net EPS (GAAP) | NA | NA | NA | NA | NA |